nach oben

Erschienen in:

01.06.2023 | News item

Detailed anaphylaxis ADR reports important

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Detailed adverse drug reaction (ADR) reports of anaphylaxis are important, says the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) in Prescriber Update . Medsafe is encouraging healthcare professionals to report all suspected or confirmed cases of medicine-induced anaphylasxis to the Centre for Adverse Reactions Monitoring (CARM), providing as much detail as possible, so that CARM can add an appropriate alert to the national Medical Warning System (MWS). …

Reporting anaphylaxis? It's all in the detail Prescriber Update 44: 26-28, No. 2, et al. Jun 2023. Available from: URL: https://www.medsafe.govt.nz/profs/PUArticles/June2023/Reporting-anaphylaxis-all-in-the-detail.html

Titel: Detailed anaphylaxis ADR reports important
Publikationsdatum: 01.06.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-41671-0

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Detailed anaphylaxis ADR reports important

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Paclitaxel/pembrolizumab

Multiple drug

Carboplatin/paclitaxel

Antineoplastic drugs

Tozinameran

Hydroxychloroquine/prednisolone/tacrolimus